LivaNova
| Private | |
| Traded as | : NASDAQ: LIVN S&P 400 Component |
| Founded | London, England, UK (2015) |
| Headquarters | 5 Merchant Square North Wharf Road London W2 1AY United Kingdom |
|
Key people
|
André-Michel Ballester, Chief Executive Officer |
| Products | Medical devices for cardiac surgery, neuromodulation and cardiac rhythm management |
| Website | http://www.livanova.com |
LivaNova, PLC is a London, England-based medical device manufacturer. The company develops devices used for cardiac surgery, neuromodulation and cardiac rhythm management. The company was formed by a 2015 $2.7B merger between Houston, TX-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on both the London Stock Exchange and NASDAQ.
Cyberonics, Inc. was founded in Houston in 1987. Sorin, also known as Sorin Group, was founded in 1956 by Fiat and Montedison, Italy's two largest industrial groups at that time. The name is an acronym for Società Ricerche Impianti Nucleari (Company for Nuclear Plant Research). In March 2015, the companies announced they would be merging in a $2.7B transaction. The transaction closed and the company began trading under the new stock symbol on Oct. 19. 2015.
The new combined company announced in May 2015 that it was focused on three product categories and will operate as three business units. The three units are cardiac surgery, with its operating HQ in Italy, cardiac rhythm management, with its operating HQ in France, and neuromodulation, with its operating HQ in Houston.
...
Wikipedia